Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2011

01.01.2011 | Original Article

Predictors of Clinical and Endoscopic Findings in Differentiating Crohn’s Disease from Intestinal Tuberculosis

verfasst von: Xuefeng Li, Xiaowei Liu, Yiyou Zou, Chunhui Ouyang, Xiaoping Wu, Minghuan Zhou, Linlin Chen, Lingjuan Ye, Fanggen Lu

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

There are many similarities and overlaps in clinical manifestations and ileocolonoscopic features between Crohn’s disease (CD) and intestinal tuberculosis (ITB). Differentiation between CD and ITB is of great importance.

Aim

To investigate the values of clinical and endoscopic findings in differential diagnosis between CD and ITB.

Methods

Clinical and endoscopic features of a cohort of 130 cases of CD and 122 cases of ITB from June 2003 to February 2009 were retrospectively reviewed following predetermined criteria. Parameters were screened by logistic regression analysis. Furthermore, the diagnostic efficacy of screened parameters was analyzed by regression equation (mathematical model) and receiver operating characteristic curve (ROC curve).

Results

The clinical features helpful in differentiating CD from ITB are hematochezia, intestinal surgery, perianal diseases, pulmonary tuberculosis, ascites, and positive of PPD skin test; the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of regression mathematical model established by clinical features were 90.3, 76.8, 83.8, 80.7, and 88.0%, respectively. The endoscopic features helpful in differentiating CD from ITB were rectum involved lesions, longitudinal ulcer, cobblestone appearance, fixed-open ileocecal valve, transverse ulcer, and rodent ulcer; the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of regression mathematical model established by endoscopic features were 82.9, 82.0, 82.5, 82.9, and 82.0%, respectively.

Conclusions

It was proposed that a diagnostic algorithm based on available clinical and endoscopic regression equation could improve the current sensitivity, specificity, and accuracy in differentiating between CD from ITB.
Literatur
1.
Zurück zum Zitat Lai CC, Lee TC, Hsiao CH, et al. Differential diagnosis of Crohn’s disease and intestinal tuberculosis by enzyme-linked immunospot assay for interferon-gamma. Am J Gastroenterol. 2009;104:2121–2122.CrossRefPubMed Lai CC, Lee TC, Hsiao CH, et al. Differential diagnosis of Crohn’s disease and intestinal tuberculosis by enzyme-linked immunospot assay for interferon-gamma. Am J Gastroenterol. 2009;104:2121–2122.CrossRefPubMed
2.
Zurück zum Zitat Ye BD, Jang BI, Jeen YT, Lee KM, Kim JS, Yang SK. Diagnostic guideline of Crohn’s disease. Korean J Gastroenterol. 2009;53:161–176.PubMed Ye BD, Jang BI, Jeen YT, Lee KM, Kim JS, Yang SK. Diagnostic guideline of Crohn’s disease. Korean J Gastroenterol. 2009;53:161–176.PubMed
3.
Zurück zum Zitat Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117:514–521.CrossRefPubMed Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117:514–521.CrossRefPubMed
4.
Zurück zum Zitat Cosnes J. Crohn’s disease phenotype, prognosis, and long-term complications: what to expect? Acta Gastroenterol Belg. 2008;71:303–307.PubMed Cosnes J. Crohn’s disease phenotype, prognosis, and long-term complications: what to expect? Acta Gastroenterol Belg. 2008;71:303–307.PubMed
5.
Zurück zum Zitat Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670–1689.CrossRefPubMed Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670–1689.CrossRefPubMed
6.
Zurück zum Zitat Amarapurkar DN, Patel ND, Rane PS. Diagnosis of Crohn’s disease in India where tuberculosis is widely prevalent. World J Gastroenterol. 2008;14:741–746.CrossRefPubMed Amarapurkar DN, Patel ND, Rane PS. Diagnosis of Crohn’s disease in India where tuberculosis is widely prevalent. World J Gastroenterol. 2008;14:741–746.CrossRefPubMed
7.
Zurück zum Zitat Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK. Crohn’s disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2009;54:1099–1107.CrossRefPubMed Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK. Crohn’s disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2009;54:1099–1107.CrossRefPubMed
8.
Zurück zum Zitat Goh K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis. 2009;10:1–6.CrossRefPubMed Goh K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis. 2009;10:1–6.CrossRefPubMed
9.
Zurück zum Zitat Kirsch R, Pentecost M, Hall Pde M, Epstein DP, Watermeyer G, Friederich PW. Role of colonoscopic biopsy in distinguishing between Crohn’s disease and intestinal tuberculosis. J Clin Pathol. 2006;59:840–844.CrossRefPubMed Kirsch R, Pentecost M, Hall Pde M, Epstein DP, Watermeyer G, Friederich PW. Role of colonoscopic biopsy in distinguishing between Crohn’s disease and intestinal tuberculosis. J Clin Pathol. 2006;59:840–844.CrossRefPubMed
10.
Zurück zum Zitat Patel N, Amarapurkar D, Agal S, et al. Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol. 2004;19:1240–1246.CrossRefPubMed Patel N, Amarapurkar D, Agal S, et al. Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol. 2004;19:1240–1246.CrossRefPubMed
11.
Zurück zum Zitat Epstein D, Watermeyer G, Kirsch R. Review article: the diagnosis and management of Crohn’s disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther. 2007;25:1373–1388.CrossRefPubMed Epstein D, Watermeyer G, Kirsch R. Review article: the diagnosis and management of Crohn’s disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther. 2007;25:1373–1388.CrossRefPubMed
12.
Zurück zum Zitat Jayanthi V, Robinson RJ, Malathi S, et al. Does Crohn’s disease need differentiation from tuberculosis? J Gastroenterol Hepatol. 1996;11:183–186.CrossRefPubMed Jayanthi V, Robinson RJ, Malathi S, et al. Does Crohn’s disease need differentiation from tuberculosis? J Gastroenterol Hepatol. 1996;11:183–186.CrossRefPubMed
13.
Zurück zum Zitat Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53(Suppl 5):V1–V16.CrossRefPubMed Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53(Suppl 5):V1–V16.CrossRefPubMed
14.
Zurück zum Zitat Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640.CrossRefPubMed Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640.CrossRefPubMed
15.
Zurück zum Zitat Marra F, Cox VC, FitzGerald JM, Moadebi S, Elwood RK. Successful treatment of multidrug-resistant tuberculosis following drug-induced hepatic necrosis requiring liver transplant. Int J Tuberc Lung Dis. 2004;8:905–909.PubMed Marra F, Cox VC, FitzGerald JM, Moadebi S, Elwood RK. Successful treatment of multidrug-resistant tuberculosis following drug-induced hepatic necrosis requiring liver transplant. Int J Tuberc Lung Dis. 2004;8:905–909.PubMed
16.
Zurück zum Zitat Kam KM, Yip CW. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995–2002, after the implementation of DOTS-plus. Int J Tuberc Lung Dis. 2004;8:760–766.PubMed Kam KM, Yip CW. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995–2002, after the implementation of DOTS-plus. Int J Tuberc Lung Dis. 2004;8:760–766.PubMed
17.
Zurück zum Zitat Wong WM, Lai KC, Yiu WC, Wong BC, Chan FL, Lai CL. Intestinal tuberculosis mimicking fistulizing Crohn’s disease. J Gastroenterol Hepatol. 2007;22:137–139.CrossRefPubMed Wong WM, Lai KC, Yiu WC, Wong BC, Chan FL, Lai CL. Intestinal tuberculosis mimicking fistulizing Crohn’s disease. J Gastroenterol Hepatol. 2007;22:137–139.CrossRefPubMed
18.
Zurück zum Zitat Sanders DS. The differential diagnosis of Crohn’s disease and ulcerative colitis. Baillieres Clin Gastroenterol. 1998;12:19–33.CrossRefPubMed Sanders DS. The differential diagnosis of Crohn’s disease and ulcerative colitis. Baillieres Clin Gastroenterol. 1998;12:19–33.CrossRefPubMed
19.
Zurück zum Zitat Yao T, Matsui T, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43:S85–S93.CrossRefPubMed Yao T, Matsui T, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43:S85–S93.CrossRefPubMed
20.
Zurück zum Zitat Winther KV, Fogh P, Thomsen OO, Brynskov J. Inflammatory bowel disease (ulcerative colitis and Crohn’s disease): diagnostic criteria and differential diagnosis. Drugs Today (Barc). 1998;34:935–942. Winther KV, Fogh P, Thomsen OO, Brynskov J. Inflammatory bowel disease (ulcerative colitis and Crohn’s disease): diagnostic criteria and differential diagnosis. Drugs Today (Barc). 1998;34:935–942.
21.
Zurück zum Zitat Pulimood AB, Peter S, Ramakrishna B, et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn’s disease. J Gastroenterol Hepatol. 2005;20:688–696.CrossRefPubMed Pulimood AB, Peter S, Ramakrishna B, et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn’s disease. J Gastroenterol Hepatol. 2005;20:688–696.CrossRefPubMed
22.
Zurück zum Zitat Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn’s disease: a diagnostic challenge. Am J Gastroenterol. 2009;104:1003–1012.CrossRefPubMed Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn’s disease: a diagnostic challenge. Am J Gastroenterol. 2009;104:1003–1012.CrossRefPubMed
23.
Zurück zum Zitat Simpson P, Papadakis KA. Endoscopic evaluation of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1287–1297.CrossRefPubMed Simpson P, Papadakis KA. Endoscopic evaluation of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1287–1297.CrossRefPubMed
Metadaten
Titel
Predictors of Clinical and Endoscopic Findings in Differentiating Crohn’s Disease from Intestinal Tuberculosis
verfasst von
Xuefeng Li
Xiaowei Liu
Yiyou Zou
Chunhui Ouyang
Xiaoping Wu
Minghuan Zhou
Linlin Chen
Lingjuan Ye
Fanggen Lu
Publikationsdatum
01.01.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1231-4

Weitere Artikel der Ausgabe 1/2011

Digestive Diseases and Sciences 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.